Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2022

View Archived Issues

2-Benzyllawsone shown to protect mice against polymicrobial sepsis

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

Council of Scientific and Industrial Research patents nigericin derivatives

New psilocin prodrugs discovered at Compass Pathfinder

Novel antibacterials synthesized at the University of Jordan

Cybin IRL describes new 5-HT2 receptor agonists

LCFA-CoA inhibits NME1 and regulates cancer metastasis

TSC2 blockade activates mTORC1, improves photoreceptor survival and delays vision loss in RP

NuclixBio and PharmAbcine enter collaborative research agreement

Catamaran expands research collaboration with University of Minnesota on CAR-NK cell engineering

NexImmune enters melanoma research and evaluation collaboration with NYU Langone center

NSF grant supports Iaso's vaccine delivery research targeting infectious diseases and cancer

Gadeta advances GDT-201 toward IND filing for colorectal cancer

SIWA-318H shows efficacy in immune-competent humanized mouse xenograft model for pancreatic cancer

Mer inhibition as a promising new therapeutic strategy against septic ALI/ARDS

Activating activators is strategy against apoptosis defectors

FDA approves IND application for SM-17 for asthma

Elektrofi and Immunoprecise collaborate on self-administered formulation of PolyTope TATX-03

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...